# OnCo record paper-burstein-tnbc-genomic-subtypes-ccr-2015 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-burstein-tnbc-genomic-subtypes-ccr-2015/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-burstein-tnbc-genomic-subtypes-ccr-2015" ;
  schema:name "Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer"@en ;
  schema:description "A 2015 Baylor study of 198 triple-negative tumours that found four stable subtypes, luminal androgen receptor, mesenchymal, basal-like immune-suppressed and basal-like immune-activated, with the immune-activated group faring best and the immune-suppressed worst."@en ;
  schema:url <https://onco.cc/key-papers/paper-burstein-tnbc-genomic-subtypes-ccr-2015/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1158/1078-0432.CCR-14-0432>, <https://pubmed.ncbi.nlm.nih.gov/25208879/> ;
  onco:tag "tnbc-evidence" ;
  schema:sameAs <https://doi.org/10.1158/1078-0432.CCR-14-0432> ;
  schema:datePublished "2015"^^xsd:gYear ;
  schema:author "Burstein MD, Tsimelzon A, Poage GM, et al." ;
  onco:related <https://onco.cc/key-papers/paper-lehmann-tnbc-subtypes-jci-2011/> ;
  onco:cancers <https://onco.cc/cancers/tnbc/> ;
  onco:technologies <https://onco.cc/technologies/rna-seq/> ;
  onco:targets <https://onco.cc/targets/androgen-receptor/>, <https://onco.cc/targets/b7h4/>, <https://onco.cc/targets/fgfr2/>, <https://onco.cc/targets/pdgfrb/> ;
  onco:institutions <https://onco.cc/institutions/baylor-duncan/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-tumor-heterogeneity/>, <https://onco.cc/bottlenecks/b-immunotherapy-response/> ;
  onco:journals <https://onco.cc/journals/clinical-cancer-research/> .